| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 10% | $1,663,965 | 357,842 | YA II PN, Ltd. | 16 Jun 2025 | |||
| CVI Investments, Inc. | 9.9% | $1,073,526 | 357,842 | CVI Investments, Inc. | 30 Jun 2025 | |||
| Point72 Asset Management, L.P. | 9.1% | $509,905 | 299,944 | Point72 Asset Management, L.P. | 16 Sep 2025 | |||
| L1 Capital Global Opportunities Master Fund, Ltd. | 5% | -50% | $492,900 | -$362,100 | 164,300 | -42% | L1 Capital Global Opportunities Master Fund, Ltd. | 14 Aug 2025 |
| BANK OF AMERICA CORP /DE/ | 0% | -100% | $125 | -$715,879 | 86 | -100% | BANK OF AMERICA CORP /DE/ | 31 Oct 2025 |
As of 30 Sep 2025, 12 institutional investors reported holding 493,997 shares of Aptevo Therapeutics Inc. - Common Stock (APVO). This represents 15% of the company’s total 3,295,607 outstanding shares.
The largest institutional shareholders of Aptevo Therapeutics Inc. - Common Stock (APVO) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 9.1% | 299,944 | 0% | $434,919 | |
| DRW Securities, LLC | 4% | 131,480 | 0.01% | $190,646 | |
| Virtu Financial LLC | 1.2% | 38,282 | 0% | $56,000 | |
| Focus Partners Wealth | 0.3% | 10,000 | 0% | $14,500 | |
| OSAIC HOLDINGS, INC. | 0.2% | 6,500 | +100% | 0% | $9,760 |
| UBS Group AG | 0.17% | 5,673 | 0% | $8,226 | |
| Tower Research Capital LLC (TRC) | 0.04% | 1,445 | +21% | 0% | $2,095 |
| SBI Securities Co., Ltd. | 0.02% | 570 | -3.1% | 0% | $827 |
| CITIGROUP INC | 0% | 74 | 0% | $107 | |
| BANK OF AMERICA CORP /DE/ | 0% | 27 | +800% | 0% | $39 |
| BlackRock, Inc. | 0% | 1 | 0% | 0% | $1 |
| DANSKE BANK A/S | 0% | 1 | 0% | 0% | $1 |